COVID SCIENCE-Virus does not threaten US blood supply; … – Thomson Reuters Foundation

Our Standards: The Thomson Reuters Trust Principles.

Coronavirus does not threaten U.S. blood supply Current guidelines for evaluating U.S. blood donors for signs of COVID-19 and for a history of recent infections are efficiently protecting the blood supply from contamination with the brand-new coronavirus, researchers say. “Other studies have actually shown that in uncommon cases where a blood sample evaluated favorable, transmission by blood transfusion has actually not occurred,” coauthor Sonia Bakkour of the University of California, San Francisco, stated in a statement. (https://bit.ly/3g62hqA) Immune system workaround helps blood cancer patients with COVID-19 In blood cancer clients who lack antibody-producing cells, other immune cells can compensate to assist fight the coronavirus, new research shows.

Coronavirus does not threaten U.S. blood supply Current guidelines for screening U.S. blood donors for signs of COVID-19 and for a history of current infections are successfully securing the blood supply from contamination with the new coronavirus, scientists state. In a study carried out for the National Institutes of Health, scientists tested nearly 18,000 “minipools” of blood samples– that is, blood samples pooled from overall of roughly 258,000 donors from across the nation. “Other research studies have actually shown that in uncommon cases where a blood sample checked positive, transmission by blood transfusion has not happened,” coauthor Sonia Bakkour of the University of California, San Francisco, said in a declaration. (https://bit.ly/3g62hqA) Immune system workaround assists blood cancer clients with COVID-19 In blood cancer patients who lack antibody-producing cells, other immune cells can compensate to assist battle the coronavirus, new research study programs. Blood cancer patients in the study were more most likely to die from COVID-19 than patients with strong growths or without cancer.